Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bionik Laboratories's Average Total Inventories for the quarter that ended in Mar. 2023 was $1.09 Mil. Bionik Laboratories's Revenue for the
three
months ended in Mar. 2023 was $0.50 Mil.
Bionik Laboratories's Inventory-to-Revenue for the quarter that ended in Mar. 2023 was 2.17.
Bionik Laboratories's Inventory-to-Revenue for the quarter that ended in Mar. 2023
increased
from Dec. 2022 (2.17) to Dec. 2022 (2.17)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bionik Laboratories's Days Inventory for the
three
months ended in Mar. 2023 was 402.31.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bionik Laboratories's Inventory Turnover for the quarter that ended in Mar. 2023 was 0.23.
Bionik Laboratories Inventory-to-Revenue Historical Data
The historical data trend for Bionik Laboratories's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bionik Laboratories's Inventory-to-Revenue
For the Medical Care Facilities subindustry, Bionik Laboratories's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bionik Laboratories's Inventory-to-Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Bionik Laboratories's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bionik Laboratories's Inventory-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bionik Laboratories's Days Inventory for the
three
months ended in Mar. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bionik Laboratories Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Bionik Laboratories's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Bionik Laboratories (Bionik Laboratories) Business Description
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BNKL has been successfully added to your 